14-day Premium Trial Subscription Try For FreeTry Free
Warren Buffett's Berkshire Hathaway has reached record-high levels of cash, with $157 billion on hand, exceeding Disney's market capitalization. The last time Buffett held record cash levels was in la
Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both assets is attractive because leveraged assets erode ov

LABU: A Levered ETF Doomed From The Start

01:08pm, Sunday, 20'th Aug 2023
The Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU) is a high-risk, leveraged ETF that aims to yield three times the performance of the S&P Biotechnology Select Industry Index. The biotech sector
High trading volume indicates high liquidity, which is a key characteristic of ETFs.
LABU is a 3X leveraged fund that has disappointed the biotech bulls. The sector looks beaten and perhaps cheap relative to long-term prospects. LABU can work for medium term returns if two requirement

Top Performing Leveraged/Inverse ETFs: 05/07/2023

04:43pm, Wednesday, 10'th May 2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
The month of April was marked by huge volatility. Though recession fears continued to weigh on investors sentiment, cooling inflation and better-than-expected earnings drove the stocks higher.

5 Best Inverse/Leveraged ETFs of Last Week

09:09am, Tuesday, 25'th Apr 2023
Wall Street offered a flat performance last week.

Leveraged Biotech ETFs: Hold LABU, Sell LABD

02:13pm, Wednesday, 19'th Apr 2023
SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, t
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. This ETF attempts to mimic 3X the one-d

LABU: Leveraged Biotech ETF Review

06:20pm, Tuesday, 31'st Jan 2023
Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap a

10 Most-Heavily Traded ETFs of Fourth-Quarter 2022

03:05pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Thee ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil. This has resulted in enough liquidity, with most of the ETFs trading at extremely higher volumes.

Top Performing Leveraged/Inverse ETFs: 12/04/2022

06:59pm, Wednesday, 07'th Dec 2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Best Inverse/Leveraged ETFs of Last Week

01:00pm, Monday, 05'th Dec 2022 Zacks Investment Research
Last week was marked with record Cyber Monday online shopping, Fed cues of slower rate hike and upbeat U.S. jobs data.

Best Inverse/Leveraged ETFs of Last Week

09:02am, Monday, 05'th Dec 2022
Last week was marked with record Cyber Monday online shopping, Fed cues of slower rate hike and upbeat U.S. jobs data.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE